These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 26893576)

  • 1. Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issues.
    Gekas J; Langlois S; Ravitsky V; Audibert F; van den Berg DG; Haidar H; Rousseau F
    Appl Clin Genet; 2016; 9():15-26. PubMed ID: 26893576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "I think we've got too many tests!": Prenatal providers' reflections on ethical and clinical challenges in the practice integration of cell-free DNA screening.
    Gammon BL; Kraft SA; Michie M; Allyse M
    Ethics Med Public Health; 2016; 2(3):334-342. PubMed ID: 28180146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.
    Badeau M; Lindsay C; Blais J; Nshimyumukiza L; Takwoingi Y; Langlois S; Légaré F; Giguère Y; Turgeon AF; Witteman W; Rousseau F
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011767. PubMed ID: 29125628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical Aspects of Prenatal DNA Testing.
    Stanić Ž; Hrgović Z; Fureš R; Vusić I; Lagančić M
    Z Geburtshilfe Neonatol; 2022 Oct; 226(5):300-303. PubMed ID: 36037825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding Use of cfDNA Screening in Pregnancy: Current and Emerging Ethical, Legal, and Social Issues.
    Parham L; Michie M; Allyse M
    Curr Genet Med Rep; 2017 Mar; 5(1):44-53. PubMed ID: 38089918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals.
    Kater-Kuipers A; Bunnik EM; de Beaufort ID; Galjaard RJH
    BMC Pregnancy Childbirth; 2018 Oct; 18(1):409. PubMed ID: 30340550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.
    Gil MM; Revello R; Poon LC; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jan; 47(1):45-52. PubMed ID: 26498918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of a universal prenatal screening program incorporating cell-free fetal DNA analysis in Ontario, Canada.
    Dougan SD; Okun N; Bellai-Dussault K; Meng L; Howley HE; Huang T; Reszel J; Lanes A; Walker MC; Armour CM
    CMAJ; 2021 Aug; 193(30):E1156-E1163. PubMed ID: 34344770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State-wide utilization and performance of traditional and cell-free DNA-based prenatal testing pathways: the Victorian Perinatal Record Linkage (PeRL) study.
    Lindquist A; Hui L; Poulton A; Kluckow E; Hutchinson B; Pertile MD; Bonacquisto L; Gugasyan L; Kulkarni A; Harraway J; Howden A; McCoy R; Da Silva Costa F; Menezes M; Palma-Dias R; Nisbet D; Martin N; Bethune M; Poulakis Z; Halliday J
    Ultrasound Obstet Gynecol; 2020 Aug; 56(2):215-224. PubMed ID: 31625225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal screening: current practice, new developments, ethical challenges.
    de Jong A; Maya I; van Lith JM
    Bioethics; 2015 Jan; 29(1):1-8. PubMed ID: 25521968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Innovative Prenatal Testing: Clinical Applications and Ethical Considerations].
    Huang MC; Lin SJ; Chen CL; Huang TJ
    Hu Li Za Zhi; 2017 Oct; 64(5):5-10. PubMed ID: 28948585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Practice Guidelines for Prenatal Aneuploidy Screening and Diagnostic Testing from Korean Society of Maternal-Fetal Medicine: (1) Prenatal Aneuploidy Screening.
    Choe SA; Seol HJ; Kwon JY; Park CW; Kim M; Lee JY; Kim MA; Hwang HS; Na S; Shim JY; Kim K; Ryu HM
    J Korean Med Sci; 2021 Jan; 36(4):e27. PubMed ID: 33496086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical, Legal and Social Issues (ELSI) Associated with Non-Invasive Prenatal Testing: Reflections on the Evolution of Prenatal Diagnosis and Procreative Choices.
    Zaami S; Orrico A; Signore F; Cavaliere AF; Mazzi M; Marinelli E
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33573312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities.
    Norton ME; Baer RJ; Wapner RJ; Kuppermann M; Jelliffe-Pawlowski LL; Currier RJ
    Am J Obstet Gynecol; 2016 Jun; 214(6):727.e1-6. PubMed ID: 26709085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective clinical trial to compare the performance of dried blood spots prenatal screening for Down's syndrome with conventional non-invasive testing technology.
    Hu H; Jiang Y; Zhang M; Liu S; Hao N; Zhou J; Liu J; Zhang X; Ma L
    Exp Biol Med (Maywood); 2017 Mar; 242(5):547-553. PubMed ID: 28056555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
    Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies.
    Huang T; Gibbons C; Rashid S; Priston MK; Bedford HM; Mak-Tam E; Meschino WS
    BMC Pregnancy Childbirth; 2020 Nov; 20(1):713. PubMed ID: 33228595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.
    Gil MM; Quezada MS; Revello R; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Mar; 45(3):249-66. PubMed ID: 25639627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.